Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

Phase 3 Unknown 480 enrolled Tasly Pharmaceuticals, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).

Timeline

Start: 2013-05
Primary completion: 2017-05
Completion: 2017-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Compound danshen dripping pills	Traditional medicine (herbal / TCM)	20 unknown	—

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

Summary

Timeline

Drugs

Indications